An $11 million verdict has been awarded to the parents of a child born with congenital defects due to an anticonvulsant drug his mother took during pregnancy.

Stanley Thompson, director of the Philadelphia Court of Common Pleas’ Complex Litigation Center, said that out of the 132 Topamax mass tort cases currently under way, Powell v. Janssen Pharmaceuticals was the second to render a verdict.